Biochemical Engineering
Adendra Therapeutics launches with $53M series A raise
7th December 2021
Apple Tree Partners has picked its first U.K.-based venture to launch: Adendra Therapeutics, an immunotherapy company focused on dendritic cell biology to treat cancers and autoimmune diseases. Adendra eked out $53 million in a series A financing to help with its launch. Source: Fierce Biotech 7/12/2021
Back to group news